ADARx Pharmaceuticals Statistics
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.33-1.25 (-6.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ADARx Pharmaceuticals by the numbers
ADARx Pharmaceuticals has a market capitalization of $1.85 billion based on 106.80M shares outstanding. With trailing EPS of $-1.16, ADARx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% below its 50-day average and 10.8% below its 200-day average.
Average daily trading volume is 1.42M shares, or about $24.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADRX valuation vs. peer median
| Metric | ADRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.85B | $1.96B | -6% |
| Avg. volume | 1.42M | 990.68K | +43% |
Peer median across 8 companies: URGN, LKFT, PRGO, MLYS, SDGR, ZYME, GPCR, AGIO.
Valuation
- Market cap
- $1.85B
- EPS (TTM)
- $-1.16
- Shares outstanding
- 106.80M
Price and trading
- Previous close
- 18.58
- Open
- 18.33
- Day range
- 17.20 – 18.70
- 52-week range
- 17.20 – 23.21
- Beta
- —
- Volume
- 705.60K
- Average volume
- 1.42M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.85B
- Eps
- -1.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.21
- Week52 Low
- 17.20
- Avg Volume
- 1.42M
- Shares Outstanding
- 106.80M
- Ma50
- 19.43
- Ma200
- 19.43
- Pct From52w High
- -25.33%
- Pct From52w Low
- 0.76%